Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telcagepant for prevention of menstrually related migraine
2010-019288-13Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine and Catamenial Migraine comparing Telcagepant with Placebo (2 arms). Primary endpoint: Mean monthly headache days while on drug. Started Apr 2010; status: completed.
02
Drugs
telcagepant
03
Conditions
migraineCatamenial Migraine
Beyond the preview
Go deeper on 2010-019288-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019288-13.